Innovative and Articulate: Vyant Bio Implements Cash Preservation Plan, Including Workforce Reduction
Vyant Bio Commences a Cash Preservation Plan Introduction CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models of…